全文获取类型
收费全文 | 5863篇 |
免费 | 491篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 46篇 |
儿科学 | 219篇 |
妇产科学 | 136篇 |
基础医学 | 779篇 |
口腔科学 | 98篇 |
临床医学 | 502篇 |
内科学 | 1466篇 |
皮肤病学 | 124篇 |
神经病学 | 531篇 |
特种医学 | 193篇 |
外国民族医学 | 1篇 |
外科学 | 870篇 |
综合类 | 53篇 |
预防医学 | 439篇 |
眼科学 | 145篇 |
药学 | 391篇 |
中国医学 | 20篇 |
肿瘤学 | 362篇 |
出版年
2023年 | 44篇 |
2022年 | 92篇 |
2021年 | 197篇 |
2020年 | 129篇 |
2019年 | 187篇 |
2018年 | 211篇 |
2017年 | 167篇 |
2016年 | 172篇 |
2015年 | 194篇 |
2014年 | 239篇 |
2013年 | 269篇 |
2012年 | 384篇 |
2011年 | 348篇 |
2010年 | 197篇 |
2009年 | 205篇 |
2008年 | 266篇 |
2007年 | 305篇 |
2006年 | 286篇 |
2005年 | 285篇 |
2004年 | 206篇 |
2003年 | 193篇 |
2002年 | 133篇 |
2001年 | 125篇 |
2000年 | 123篇 |
1999年 | 113篇 |
1998年 | 49篇 |
1997年 | 42篇 |
1996年 | 39篇 |
1995年 | 29篇 |
1994年 | 33篇 |
1993年 | 25篇 |
1992年 | 120篇 |
1991年 | 108篇 |
1990年 | 106篇 |
1989年 | 95篇 |
1988年 | 82篇 |
1987年 | 67篇 |
1986年 | 70篇 |
1985年 | 49篇 |
1984年 | 41篇 |
1983年 | 38篇 |
1982年 | 25篇 |
1979年 | 30篇 |
1978年 | 26篇 |
1977年 | 18篇 |
1974年 | 22篇 |
1972年 | 16篇 |
1971年 | 16篇 |
1969年 | 19篇 |
1966年 | 16篇 |
排序方式: 共有6375条查询结果,搜索用时 15 毫秒
101.
Sam M. Mbulaiteye Sheeja T. Pullarkat Bharat N. Nathwani Lawrence M. Weiss Nagesh Rao Benjamin Emmanuel Charles F. Lynch Brenda Hernandez Vishala Neppalli Debra Hawes Myles G. Cockburn Andre Kim Makeda Williams Sean Altekruse Kishor Bhatia Marc T. Goodman Wendy Cozen 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2014,122(1):5-15
Burkitt lymphoma (BL) occurs at all ages, but the patterns of Epstein–Barr virus (EBV) positivity in relation to human immunodeficiency virus (HIV), immunoprofiles and age have not been fully explored. BL tissues from residual tissue repositories, and two academic centers in the United States were examined by expert hematopathologists for morphology, immunohistochemistry, MYC rearrangement, EBV‐encoded RNA (EBER), and diagnosed according to the 2008 WHO lymphoma classification. Analysis was done using frequency tables, Chi‐squared statistics, and Student's t‐test. Of 117 cases examined, 91 were confirmed as BL. The age distribution was 26%, 15%, 19%, and 29% for 0–19, 20–34, 35–59, 60+ years, and missing in 11%. MYC rearrangement was found in 89% and EBER positivity in 29% of 82 cases with results. EBER positivity varied with age (from 13% in age group 0–19 to 55% in age group 20–34, and fell to 25% in age group 60+ years, p = 0.08); with race (56% in Blacks/Hispanics vs 21% in Whites/Asians/Pacific Islanders, p = 0.006); and by HIV status (64% in HIV positive vs 22% in HIV negative cases, p = 0.03). EBER positivity was demonstrated in about one‐third of tumors and it was strongly associated with race and HIV status, and marginally with age‐group. 相似文献
102.
103.
104.
Shanie Saghafian-Hedengren Ismael Söderström Eva Sverremark-Ekström Anna Nilsson 《Blood reviews》2018,32(1):71-80
Acute lymphoblastic leukaemia (ALL) is the most common type of cancer in children, accounting for approximately 25% of childhood cancer cases. As a result of effective treatments over the past decades, paediatric ALL mortality has been greatly reduced. Chemotherapy, however, has a range of harmful side effects including the loss of protective antibodies against vaccine-preventable diseases. Since ALL survivors have an increased risk of health problems including organ insufficiencies, acquired vaccine-preventable infections subsequent to clinical remission could become life threatening to these individuals. This review will summarize clinical findings regarding defective humoral immunity in ALL survivors, identify current knowledge gaps and highlight mechanisms related to deficiencies in the B-cell compartment important for serological memory. Further, we illuminate the emerging evidence for a relationship between chemotherapy and gut microbiota, which could play an important role in vaccine responses and the shaping of a young immune system subjected to maturation and recovery. 相似文献
105.
106.
107.
Magali Hernandez Bérengère Phulpin Ludovic Mansuy Dominique Droz 《Journal of oral pathology & medicine》2017,46(5):321-326
New targeted cancer therapies such as bisphosphonates, denosumab, and bevacizumab are routinely used in adult for the past decades. Their introduction into pediatric medicine is more recent that means there is a paucity of data on long‐term effects on dental development and on the risk of osteonecrosis of jaw. This study aimed to outline adverse effects of new targeted cancer therapies on oral cavity including dental abnormalities observed in pediatric population treated with these molecules and the risk of osteonecrosis of the jaw (ONJ). The impact of bisphosphonates and denosumab on bone remodeling (inhibition of osteoclasts) could interfere with teeth exfoliation and eruption processes, causing a tooth eruption delay. This hypothesis was confirmed, bisphosphonate‐treated rats presented tooth eruption delay, and bisphosphonate therapy was associated with a mean delay of 1.67 years in tooth eruption in children with osteogenesis imperfecta. Another study showed that the inhibition of RANK/RANKL by denosumab was associated with a lack of tooth eruption in animals. Several animal studies reported that bisphosphonate could also induce dental abnormalities including defective amelogenesis and dentinogenesis in rats, but there is no evidence of such effects in children; only one case of enamel hypoplasia in a child treated for idiopathic arterial calcification with bisphosphate was reported. To date, there has been no reported case of ONJ in children treated with bisphosphonates, denosumab, or bevacizumab. 相似文献
108.
Fernando Alfonso Maria J. Pérez-Vizcayno Jaime Dutary Javier Zueco Angel Cequier Arturo García-Touchard Vicens Martí Iñigo Lozano Juan Angel José M. Hernández José R. López-Mínguez Rafael Melgares Raúl Moreno Bernhard Seidelberger Cristina Fernández Rosana Hernandez 《JACC: Cardiovascular Interventions》2012,5(7):728-737
109.
110.